Trevor F. Carr - Concepedia

Author

Trevor F. Carr

Royal Manchester Children's Hospital

Also Known As

Trevor Carr, Trevor F. Carr

Publications

380

Citations

H-Index

Concepts

All Affiliations

Royal Manchester Children's Hospital The Christie Hospital University of Manchester

About

Trevor F. Carr is an author at Royal Manchester Children's Hospital specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	244
2	Immunology	3	3	131
3	Marrow Transplantation	3	3	197
4	Blood Transplantation	2	2	69
5	Cell Biology	1	1	28

Trevor F. Carr

Publications

351

Citations

H-Index

Page 1

	Year	Citations
Use of Enzyme Replacement Therapy (Laronidase) before Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis I: Experience in 18 Patients Robert Wynn, Jean Mercer, Joanne Page, The Journal of Pediatrics TransplantationMarrow TransplantationEnzyme Replacement TherapyStem Cell TransplantationHematology	2008	85
Treosulfan‐containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non‐malignant disease and significant co‐morbidities Brigit Greystoke, Sonia Bonanomi, Trevor F. Carr, British Journal of Haematology Total Treosulfan DoseTransplantationMarrow TransplantationHigh RatesFamily Donor Sct	2008	62
Improved Outcome From Invasive Adenovirus Infection in Pediatric Patients After Hemopoietic Stem Cell Transplantation Using Intensive Clinical Surveillance and Early Intervention Ponni Sivaprakasam, Trevor F. Carr, Mary Coussons, Journal of Pediatric Hematology/Oncology Invasive Adenovirus InfectionTransplantationPediatric HematologyStem Cell TransplantationHematology	2007	50
Retrovirally mediated correction of bone marrow–derived mesenchymal stem cells from patients with mucopolysaccharidosis type I M. Baxter, Robert Wynn, Jonathan A. Deakin, Blood	2002	42
The impact of monitoring Epstein–Barr virus PCR in paediatric bone marrow transplant patients: Can it successfully predict outcome and guide intervention? Hayley M. Greenfield, Maged I. Gharib, Andrew Turner, Pediatric Blood & Cancer	2005	37
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma Nick Thatcher, G.R. Morgenstern, Trevor F. Carr, Cancer	1989	28
A cross‐linker‐sensitive myeloid leukemia cell line from a 2‐year‐old boy with severe Fanconi anemia and biallelic <i>FANCD1</i>/<i>BRCA2</i> mutations Stefan Meyer, William Fergusson, Anneke B. Oostra, Genes Chromosomes and Cancer Hematological MalignancyChromatinInherited Mmc SensitivityMmc SensitivitySevere Fanconi Anemia	2005	28
Juvenile Myelomonocytic Leukemia Presenting With Features of Neonatal Hemophagocytic Lymphohistiocytosis and Cutaneous Juvenile Xanthogranulomata and Successfully Treated With Allogeneic Hemopoietic Stem Cell Transplant Deepa J. Arachchillage, Trevor F. Carr, Bronwyn Kerr, Journal of Pediatric Hematology/Oncology Hematological MalignancyHlh TherapyTransplantationBone Marrow FailurePediatric Hematology	2010	19

Page 1